Psychedelic Capital Sept - The gold standard for psychedelic investment

Psychedelic Capital Sept - The gold standard for psychedelic investment in San Francisco on Thursday, September 3, 2020
Psychedelic Capital Sept - The gold standard for psychedelic investment in San Francisco on Thursday, September 3, 2020
Thursday, September 3, 2020, 1800 - 2200
September 3rd / 1pm - 5pm / Toronto / Eastern Time

MagicMed, Aion Therapeutic Inc.
Looking at long term psychedelic drug discovery, the market for psychedelic clinics and how the two sectors will interact as the industry evolves.

The Conscious Fund
Understanding how responsible go public tracks and sustainable IPO models will become key parts of the psychedelic investment ecosystem.

An investor conference series diving deep into psychedelic medicine investment. Each month, we present a curated group of CEOs, capital advisors, and investment luminaries from around the world.

Each session features two tracks. The first looks at the bigger picture, helping investors understand the psychedelic landscape. The second is a chance to hear from the hottest companies directly, in conversation with our experts.

The topics we explore include:
Public Markets and IPOs
Early Stage Opportunities
Business and Operations
Law and Regulation
The Future

MagicMed Industries intends to partner with pharmaceutical and other companies to develop psychedelic-derived medicinal and licit consumer goods products. MagicMed's molecular derivatives library, the Psybrary™ is anticipated to be an essential building block from which industry can develop new patented products. The initial focus of the Psybrary™ is on psilocybin, and is expected to be opportunistically expanded to other psychedelics like MDMA, ketamine, ibogaine, mescaline, and ayahuasca.

Stephen Hays
Managing Partner, What If Ventures
Stephen Hays is the founder of What If Ventures, a VC fund investing primarily in early-stage tech startups focused on solutions in mental health and addiction recovery. After decades struggling with addiction, and type-1 bi-polar disorder, Stephen was able to experience a transformative change in his life with the help of his loving wife and children, his father, and close friends.

Timothy Regan
VP, Capital Markets, KCSA Strategic Communications
Tim's capital market and corporate advisory experience developed through deep institutional relationships both on the buy-side and sell-side with clients all over the world including the US, Canada, South America, Asia and the EU.

The Conscious Fund invests in early stage ventures in plant powered medicine. We are helping the psychedelic medicine space to grow ethically and sustainably through our work with Seed to Series A companies.

Microdose is the source for psychedelic insights spanning events, videocasts and podcasts, insider news and balanced reporting on the space. From investment through science to patient pathways, we've got it covered.

Psyindex is a media partner with the leading psychedelics index, powered by CFN Enterprises Inc. (OTCQB: CNFN). A leading agency and financial media network dedicated to the cannabis industry, CFN helps private, pre-public and public cannabis companies in the US and Canada attract capital, investors and media attention.

In addition to our huge Virtual Psychedelic Conference where 1,100 experts gathered to hear 100+ speakers over 2 days. We've also held several investment summits across Europe, including London, Malta and Luxembourg.

Through these events we have hosted thousands of investors and international cannabis and psychedelics companies. Attendees included UHNWIs, Family Offices, and VCs with a combined AUM of €15bn+.

Sponsors present and showcase their companies to our diverse network of investors, including UHNWIs, Family Offices, VCs, PEs and other Funds.

All tickets are offered on a first-come first-served basis. If you are an accredited or high net worth investor, please contact us for a complimentary ticket at

If you are an accredited member of the press, please contact us for a media pass at

* Please note that companies and speakers may change from time to time. The sector is so busy that we occasionally have to make amendments on short notice.

Standard Investor: USD 130.0

Speakers: Timothy Regan VP, Capital Markets, KCSA Strategic Communications, Stephen Hays Managing Partner, What If Ventures, Dr. Joseph Tucker, Founder and CEO, MagicMed Industries
Starting Price Per Person
$ 130.00 USD
Other Information
San Francisco 00000
United States
( Multi-Purpose Events Venue )

Event Organizer Contact
Microdose Psychedelic Insights

More Events
Event ID: 173469

Get Events in Your Inbox

We have over 100,000 Events in 80+ Categories. Tell us what type of events you like, and we will send them to your inbox